CN105101957A - 快速有效治疗缺铁性贫血的铁基纳米复合物新配方 - Google Patents

快速有效治疗缺铁性贫血的铁基纳米复合物新配方 Download PDF

Info

Publication number
CN105101957A
CN105101957A CN201380074286.1A CN201380074286A CN105101957A CN 105101957 A CN105101957 A CN 105101957A CN 201380074286 A CN201380074286 A CN 201380074286A CN 105101957 A CN105101957 A CN 105101957A
Authority
CN
China
Prior art keywords
iron
vitamin
nanocomposite
anemia
iron oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380074286.1A
Other languages
English (en)
Chinese (zh)
Inventor
莫那·巴克·默罕默德·艾哈迈迪
谢瑞恩·哈桑·阿巴斯·赫麦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROP EGYPTIAN PHARMACEUTICAL IND EEPI
NANOTECH FOR PHOTOELECTRONICS RES
Original Assignee
EUROP EGYPTIAN PHARMACEUTICAL IND EEPI
NANOTECH FOR PHOTOELECTRONICS RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROP EGYPTIAN PHARMACEUTICAL IND EEPI, NANOTECH FOR PHOTOELECTRONICS RES filed Critical EUROP EGYPTIAN PHARMACEUTICAL IND EEPI
Publication of CN105101957A publication Critical patent/CN105101957A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN201380074286.1A 2013-03-06 2013-10-29 快速有效治疗缺铁性贫血的铁基纳米复合物新配方 Pending CN105101957A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EG2013030371 2013-03-06
EG2013030371 2013-03-06
PCT/EG2013/000027 WO2014135170A1 (en) 2013-03-06 2013-10-29 Novel formula of iron based nanocomposites for rapid and efficient treatment of iron deficiency anemia

Publications (1)

Publication Number Publication Date
CN105101957A true CN105101957A (zh) 2015-11-25

Family

ID=51490651

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380074286.1A Pending CN105101957A (zh) 2013-03-06 2013-10-29 快速有效治疗缺铁性贫血的铁基纳米复合物新配方

Country Status (6)

Country Link
US (1) US20160022733A1 (https=)
EP (1) EP2964205A4 (https=)
JP (1) JP2016511261A (https=)
CN (1) CN105101957A (https=)
BR (1) BR112015021212A2 (https=)
WO (1) WO2014135170A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602914A (zh) * 2019-01-08 2019-04-12 扬州大学 维生素b2修饰的铁基纳米酶及其制备方法和应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102085115B1 (ko) * 2017-07-21 2020-03-05 스노우화이트팩토리(주) 마그헤마이트-사포닌 나노결합체를 유효성분으로 함유하는 조혈기능 장애 질환 예방 또는 치료용 약학조성물
WO2024100213A1 (fr) 2022-11-10 2024-05-16 Université De Lorraine Nanoclusters de fer, leurs procédés d'obtention et leurs utilisations pour lutter contre les carences en fer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065521A1 (en) * 2005-09-19 2007-03-22 Bala Venkataraman Composition and method for treating iron deficiency anemia
WO2009120702A2 (en) * 2008-03-25 2009-10-01 Emory University Elemental iron nanoparticles
WO2010034319A1 (en) * 2008-09-29 2010-04-01 Innovative Research And Development Co. (Inrad) Magnetite nanoparticles as a single dose treatment for iron deficiency anemia
WO2012092305A2 (en) * 2010-12-27 2012-07-05 Incube Labs, Llc Nanonized iron compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI321133B (en) * 2006-08-01 2010-03-01 Univ Kaohsiung Medical Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)
JP4793202B2 (ja) * 2006-09-27 2011-10-12 大日本印刷株式会社 壁紙
CN102730767B (zh) * 2012-06-13 2014-05-21 湖北工业大学 一种纳米α-氧化铁粉体的快速制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065521A1 (en) * 2005-09-19 2007-03-22 Bala Venkataraman Composition and method for treating iron deficiency anemia
WO2009120702A2 (en) * 2008-03-25 2009-10-01 Emory University Elemental iron nanoparticles
WO2010034319A1 (en) * 2008-09-29 2010-04-01 Innovative Research And Development Co. (Inrad) Magnetite nanoparticles as a single dose treatment for iron deficiency anemia
WO2012092305A2 (en) * 2010-12-27 2012-07-05 Incube Labs, Llc Nanonized iron compositions and methods of use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
李占山等: "维生素B2与铁剂联合用药对孕期缺铁性贫血的协同治疗效果观察", 《中国综合临床》 *
焦广宇等: "铁加维生素C改善缺铁性贫血试验研究", 《中国公共卫生》 *
邓俊泉: "维生素B6在缺铁性贫血治疗中的作用观察", 《新医学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109602914A (zh) * 2019-01-08 2019-04-12 扬州大学 维生素b2修饰的铁基纳米酶及其制备方法和应用
CN109602914B (zh) * 2019-01-08 2022-05-17 扬州大学 维生素b2修饰的铁基纳米酶及其制备方法和应用

Also Published As

Publication number Publication date
BR112015021212A2 (pt) 2017-07-18
EP2964205A1 (en) 2016-01-13
US20160022733A1 (en) 2016-01-28
WO2014135170A1 (en) 2014-09-12
JP2016511261A (ja) 2016-04-14
EP2964205A4 (en) 2016-07-27

Similar Documents

Publication Publication Date Title
Kumari et al. Iron nanoparticles as a promising compound for food fortification in iron deficiency anemia: a review
Kiouri et al. Multifunctional role of zinc in human health: an update
JP7123945B2 (ja) がん放射線療法を増強するための組成物および方法
Mosulishvili et al. Experimental substantiation of the possibility of developing selenium-and iodine-containing pharmaceuticals based on blue–green algae Spirulina platensis
JP2025120284A (ja) 魚油とセレンとを含む栄養サプリメント
CN110198742B (zh) 一种纳米炭-铁复合体系及其组合物、制备方法和用途
Elshemy Iron oxide nanoparticles versus ferrous sulfate in treatment of iron deficiency anemia in rats
Shafie et al. The effects of nanoparticles containing iron on blood and inflammatory markers in comparison to ferrous sulfate in anemic rats
Singh et al. Nano-formulations in treatment of iron deficiency anaemia: an overview
Elsayed et al. Treatment of anemia progression via magnetite and folate nanoparticles in vivo
Zhu et al. Effects of carbonyl iron powder on iron deficiency anemia and its subchronic toxicity
Sun et al. Effect of hemoglobin extracted from Tegillarca granosa on iron deficiency anemia in mice
CN105101957A (zh) 快速有效治疗缺铁性贫血的铁基纳米复合物新配方
US8759546B2 (en) Physical nano-complexes for preventing and treating cancer and method for manufacturing the same
Islam Angiostatic effects of ascorbic acid: current status and future perspectives
KR101243406B1 (ko) 암 화학 요법시에 일어나는 산화 스트레스 및/또는 부작용의 경감 혹은 암 화학 요법시의 영양 상태를 개선하기 위한 조성물
JP7012724B2 (ja) 腎臓透析を受けている患者のための食餌性多量／微量栄養補給剤
Aycicek Ferrous sulfate versus ferrous fumarate plus zinc sulfate and vitamin C for treatment of iron deficiency anemia in children
Kumari et al. Role of nanotechnology in iron deficiency.
Gromova et al. Systematic computer analysis of iron fumarate pharmacology in the treatment of iron deficiency and iron deficiency anemia
Ibrahim et al. Stannous chloride induces alterations in body weight and hematological parameters in male rabbit.
Etim et al. of Four Different Classes of Artemisinin-based Combination Therapies on Antioxidant System of Malaria-Infected Albino Mice
Smith et al. Role of Spirulina in Anemia Management and Hematopoiesis
Huang et al. Chickpea seeds ferritin as a potential source in the treatment of iron deficiency anemia
Ahmad et al. Emerging Role of Free Radicals and Therapeutic Approach towards Antioxidants in Childhood Disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151125

WD01 Invention patent application deemed withdrawn after publication